Category: News Releases

Partnership Strengthens Growing Industries Raising Private Capital

Posted on by Jason Futko

In another strategic move, KoreConX All-In-One Platform announces partnership with Fundopolis, an online investment bank specializing in exempt offerings and private placement capital allocation, as a way to keep creating more opportunities for entrepreneurs.

At first, Fundopolis was a KoreClient, attracted by its industry leading state of the art platform dedicated to processing and recordkeeping issuer and investor transactions in Exempt Capital-Raising Offerings, specifically RegCF and RegA+ offerings. Fundopolis uses KoreConX´s technology for their capital market activities.

As KorePartners, Fundopolis, a FINRA Broker-dealer registered in all 50 states, is eager to make their expertise available to the whole private capital ecosystem. With expertise in sectors such as real estate and cannabis, the online bank offers experience in these ever-expanding industries, guiding private companies as they navigate the complex regulatory space while introducing them to investors who share their vision for the future. Fundopolis is also part of the ecosystem for RegD, RegCF, and RegA+ offerings providing the FINRA broker dealer services to help companies raise capital.

“Beyond that, we understand that the investment landscape is constantly changing, and we pride ourselves on approaching the entire process with an eye on what is possible. As a recordkeeping transfer agent and escrow platform, we believe KoreConX is the perfect partner for Fundopolis, providing access to a vast ecosystem of investors and issuers,” says Bert Pearsall, CEO & Managing Principal at Fundopolis.

Co-founder and CEO at KoreConX, Oscar A. Jofre, acknowledges Fundopolis as a highly rated KorePartner. “When we first met, as a KoreClient, we saw a great potential and a lot of opportunities ahead of us. Since our solution unites tools to securely and efficiently manage business data and facilitate compliance during all the capital raising process regardless of where they are in this cycle, it was only natural to add them to our valuable team of KorePartners.”

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution. For investor relations and fundraising, the platform enables private companies to share and manage corporate records and investments: it assists with portfolio management, capitalization table and shareholder management, virtual minute book, security registration, transfer agent services, and virtual deal rooms for raising capital.

KoreConX All-In-One Platform announces partnership with Fundopolis. Read more in our blog.

KoreConX and Medtech-Ecosystem Together at LSI Emerging Medtech Summit 2022

Posted on by Peter Daneyko

Experts in the life sciences sector will teach investors how to use Regulation A+ for successful capital raising

 

NEW YORK, February 23, 2022 – KoreConX is thrilled to announce its participation at LSI Emerging Medtech Summit – USA 2022. This event will be held on March 15-18, 2022, in Dana Point, California, USA. It is led by Life Science Intelligence (LSI) and will bring together an ecosystem of experts who support medtech and life science companies to raise capital.

LSI is part of the Medtech ecosystem of KoreConX’s partners focused on Life Sciences companies. LSI offers insights to help investors and executives make decisions based on data provided by experts on their team. This vertical includes Medical Funding Professionals, a company that specializes in consulting to raise capital for pharmaceutical and medical businesses.

The group has built a value-added offering around Regulation A+ fundraising they call the Capital Planning Valuation Strategy™ (CPVS). The purpose of the CPVS approach, beyond a successful Reg A+ raise, is to help companies develop a strategic plan for their long-term capital needs that protects the interests of the founders and other early investors as these capital-intensive businesses go through R&D, clinical trials, FDA approval, and go-to-market execution.

Stephen Brock, CEO of Medical Professionals, highlights the impact of this sector: “One of the major trends in the financial world right now is impact investing. Life science—medtech, biotech, and pharma—is the ultimate impact investment. These companies are saving lives and limbs and brains—saving quality of life, as well. That’s why we do what we do.”

“In the many years I’ve been working with medtech innovators, I can’t count the number of great products I’ve seen that never make it to market for no other reason than lack of access to capital. That’s why I’m so excited about the possibility Reg A+ brings—with the new higher limits,” says Scott Pantel, CEO of LSI.

This vertical includes  FINRA Broker-Dealer (Rialto Markets), Offering Preparation (Regulation D Resources) and KoreConX, with its All-In-One Platform to support all stages of the offerings.

This team will be together at LSI Emerging Medtech Summit 2022 and attendees can participate in person or online. KoreConX will be represented by its Co-founder and CEO, Oscar A Jofre; its Chief Scientist & CTO, Dr. Kiran Garimella; and its CRO, Peter Daneyko. Visit their website for more information:  https://www.lifesciencemarketresearch.com/medtech-summit-2022

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution.

###

Media Contacts:
KoreConX
Carolina Casimiro
carolina@koreconx.com

KoreConX and David Weild IV at LSI Emerging Medtech Summit 22

Posted on by Peter Daneyko

‘Father of the JOBS Act,’ Mr. Weild will join KoreConX to address a keynote on how Medtech is the new frontier to a successful capital raising

NEW YORK, February 8, 2022 – KoreConX and its partner, Life Science Intelligence, are bringing together top thought leaders in the private capital markets environment to the Emerging Medtech Summit 2022. This summit will be held on March 15-18, 2022, in Dana Point, California, USA. It is led by Life Science Intelligence (LSI) and will host one of the most important personalities of the JOBS Act scene, David Weild IV.

Mr. Weild, a former Vice Chairman of NASDAQ, is known as one of the key players in revolutionizing the democratization of capital in the United States. His work with the U.S. Congress and his testimonial to the U.S. House of Representatives Financial Services Committee on Capital Markets resulted in the signing of the JOBS Act into law by President Barack Obama in April 2012. Since the SEC introduced the framework for Regulation A+ and its subsequent amendments, companies are able to raise up to $75 million from both accredited and non-accredited investors.

“We understand the importance of the democratization of capital through Regulation A+. David Weild, in addition to being a game-changer in the JOBS Act, is also part of our advisory board. We are absolutely thrilled to be joining him in empowering the Medtech industry to benefit from the Reg A+ exemption,” says Oscar A. Jofre, Co-founder and CEO of KoreConX.

David Weild IV also highlights how the JOBS Act is changing the healthtech and pharmaceutical industry. “It’s gratifying to see so many Medtech companies using the JOBS Act since we created it in large part to fund innovative growth companies and social impact.”

Another seasoned speaker who will be present at the event is Manny Villafaña, who is Founder, Chairman, and CEO of Medical 21. He reinforces how this exemption is a change-maker to this sector. “Regulation A+ is the 21st Century way to raise capital.” Mr. Villafaña will be sharing his experience in using Regulation A+ for pharma and Medtech companies.

LSI Emerging Medtech Summit 2022 will take place on March 15-18, 2022, at Dana Point, California, USA.  Attendees can participate in person or online. KoreConX will be represented by its Co-founder and CEO, Oscar A Jofre, its Chief Scientist & CTO, Dr. Kiran Garimella, and its CRO, Peter Daneyko. Visit their website for more information:

https://www.lifesciencemarketresearch.com/medtech-summit-2022

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution.

###

Media Contacts:
KoreConX
Carolina Casimiro
carolina@koreconx.com

KoreConX Partners With LSI Emerging Medtech Summit 2022

Posted on by Peter Daneyko


Medtech and Life Sciences main event will be held next March in California. KoreConX is one of the supporting sponsors.

NEW YORK, January 26, 2022 – KoreConX is pleased to announce its partnership with LSI Emerging Medtech Summit 2022, which will be held March 15-18, 2022, in Dana Point, California, USA. This is a major event managed by Life Science Intelligence (LSI) in the Medtech environment and will bring together investors, strategic partners, and experts within the Medtech, Life Sciences ecosystem.

Oscar A Jofre, Co-founder and CEO of KoreConX, highlights the importance of this partnership and event to the sector: “We at KoreConX are delighted to be part of this huge event focused on an industry that is flourishing like Medtech. This sector is critical to saving lives with its innovative solutions and healthcare impact. We are confident that this particular segment will reap the biggest benefits from Regulation A+, and we are honored to sponsor this summit. Also, we will be there in-person for the first time after two years, so we are more than excited to join LSI and our partners to be part of this.”

“A major current trend in the medtech industry is the democratization of capital through programs like Reg A+. We are embarking during a monumental time where we can finally achieve this grand goal and bring companies to market that have a fundamental impact in our lives,” says Scott Pantel, CEO of Life Science Intelligence.

This event will also feature the participation of an icon of the JOBS Act movement, David Weild IV, considered the “Father of the JOBS Act”. He will be giving a keynote address to stimulate and encourage everyone in this industry who wants to raise money using Regulation A+.

LSI is part of the Medtech ecosystem of KoreConX’s partners focused on Life Sciences companies. They are an essential part of this vertical, as they offer valuable insights to help investors and executives make decisions based on data provided by their team of market researchers, economists, and analysts.

LSI Emerging Medtech Summit 2022 will take place March 15-18, 2022, and attendees can participate in person or online. KoreConX will be represented by its Co-founder and CEO, Oscar A Jofre, its Chief Scientist & CTO, Dr. Kiran Garimella, and its CRO, Peter Daneyko. Visit their website for more information: https://www.lifesciencemarketresearch.com/medtech-summit-2022

About KoreConX

Founded in 2016, KoreConX is the first secure, all-in-one platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms, all leverage our eco-system solution.

###

Media Contacts:
KoreConX
Carolina Casimiro
carolina@koreconx.com

KoreConX Webinar: Why cannabis and RegA+ are the perfect match!

Posted on by Oscar Jofre

A virtual event held by KoreConX that featured Cannabis experts and Top Thoughts Leaders discussing the potential and possibilities of raising money using Regulation A+

[New York, NY – 03 November 2021 ] – The KoreSummit, an event created by KoreConX to explore major aspects of the capital raising journey, Equity Crowdfunding and technology with experts, was held last week.  Partners included Moxie, Crowdcheck Law, Carman Lehnhof Israelsen, Dalmore Group, Rialto Markets, New Direction Trust, Ext-Marketing,  and DNA (Digital Niche Agency). More than 116 companies interested in raising capital in Cannabis attended this virtual event.

Guests discussed how Cannabis and Regulation A+ fits and how to create a capital raising journey for their business. Experts from different sectors shared their experience and knowledge about all the stages in using Regulation A+ to create a successful campaign for Cannabis companies and investors. It’s important to note that this business is expanding and creating more space – as more states continue to legalize this sector, more opportunities for investments to come.

“The idea of our KoreSummit is to demystify the capital raising journey opportunities and provide education to anyone who wants to raise money for their business. With more than 11 years of living and learning how crowdfunding works, we at KoreConX want to offer free education to entrepreneurs and companies seeking to raise capital,” says Oscar Jofre, CEO and Co-founder of KoreConX. “I am an enthusiastic learner. I believe that knowledge is a key to empowering people. In addition, our partners bring a broad base of expertise that can  help people who are looking for reliable information on creating crowdfunding campaigns”.

The Cannabis KoreSummit covered all the stages of raising money and had the collaboration of lawyers, broker-dealers, compliance, and marketing experts to help participants understand this Regulation. KoreConX’s team members discussed the requirements of an “All-in-One” technology platform with solutions that unify all parts of the Reg A+ offering process. 

KoreConX will hold two more KoreSummits until December this year.  These KoreSummits will bring focus to diverse themes and sectors, such Digital Securities. Participation is always free.

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets, and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms all leverage our eco-system solution. For investor relations and fundraising, the platform enables private companies to share and manage corporate records and investments: it assists with portfolio management, capitalization table and shareholder management, virtual minute book, security registration, transfer agent services, and virtual deal rooms for raising capital. The All-In-One platform manages the full life cycle of digital securities, including their issuance, trading, clearing, settlement, management, reporting, corporate actions, and custodianship.

Media Contact:
KoreConX
Carolina Casimiro
carolina@koreconx.com

KoreConX’s KoreChain Infrastructure Leveraged by SEC-Qualified Companies Raising Capital

Posted on by Oscar Jofre

The KoreConX All-In-One Platform is the first to market with a fully compliant blockchain technology (KoreChain) to connect investors, companies, broker-dealers, secondary market ATS, and all stakeholders to the private capital markets

NEW YORK, October 27, 2021 (Newswire.com) – KoreConX’s Infrastructure of Trust launched in 2016 is a cornerstone of the private market’s capital-raising ecosystem, designed to reduce friction in every aspect of raising capital and managing large numbers of investors. Today marks a major milestone in the private markets, with KoreConX as the only company to see its technology, which is based on a permissioned blockchain, to be used by companies that have been “qualified by the SEC,” which is a first for the blockchain.

Companies that use the Infrastructure of Trust can have the assurance of working with a technology that other companies have used and received qualification by the SEC. The technology also includes regulated connected services such as a registered SEC-Transfer Agent, FINRA broker-dealer, and FINRA & SEC registered Secondary Market ATS.

The KoreChain infrastructure provides an end-to-end solution for the private markets to ensure that a company offering its digital securities, security tokens, non-fungible tokens (NFT) or stablecoins is fully compliant.

KoreConX’s End-To-End RegA+ solution allows companies raising capital to manage the full life cycle of their offering. The All-In-One platform provides complete overview from pre-during-post raise including shareholder management, monetization of investments and other features to meet compliance requirements.

These solutions are provided on a decentralized permissioned-based blockchain infrastructure technology. This permissioned-based blockchain, KoreChain, is being used by companies that have had offerings qualified with the SEC and also provides a roadmap for companies that want to issue digital securities, non-fungible tokens, and stablecoins.

To complement all the solutions that KoreConX offers, the ecosystem includes KorePartners with expertise in fields related to RegA+ like securities lawyers, FINRA broker-dealers, auditors, escrow, SEC transfers agents and investor acquisition firms.

About KoreConX

Founded in 2016, KoreConX is the first secure, All-In-One platform that manages private companies’ capital market activity and stakeholder communications. With an innovative approach and to ensure compliance with securities regulations and corporate law, KoreConX offers a single environment to connect companies to the capital markets, and now secondary markets. Additionally, investors, broker-dealers, law firms, accountants and investor acquisition firms all leverage our eco-system solution. For investor relations and fundraising, the platform enables private companies to share and manage corporate records and investments: it assists with portfolio management, capitalization table and shareholder management, virtual minute book, security registration, transfer agent services, and virtual deal rooms for raising capital. The All-In-One platform manages the full life cycle of digital securities, including their issuance, trading, clearing, settlement, management, reporting, corporate actions, and custodianship.

Media Contact:
KoreConX
Carolina Casimiro
carolina@koreconx.com

Join the all-in-one platform empowering private capital markets.

Free forever, KoreConX makes it easy for participants in private capital markets to manage their investment portfolios, raise capital, and meet global compliance standards along every step of the way.

Sign up, it's free! Book a call